Target- |
MechanismVitamin K antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date31 Jul 1944 |
The effect of Sedodex® on ventilation efficacy in patients undergoing one lung ventilation during thracic surgery
100 Clinical Results associated with Imagen Biotech, Inc.
0 Patents (Medical) associated with Imagen Biotech, Inc.
100 Deals associated with Imagen Biotech, Inc.
100 Translational Medicine associated with Imagen Biotech, Inc.